3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Melanoma
11
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Uncommon Pathological Types of Lung Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
NSCLC
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Lung Diseases, Interstitial
1
Liver Diseases
1
Kidney Neoplasms
1
Interventions
Ultrasonography
3
Walking Speed
2
Tomography, X-Ray Computed
2
Hand Strength
2
Gastrectomy
2
Esophagectomy
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
Testosterone
1
Standard of Care
1
Preoperative Exercise
1
Nivolumab
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Hepatectomy
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Colectomy
1
Chemotherapy, Adjuvant
1
Carboplatin
1
CP protocol
1
Adiposity
1
4-azidosalicylic acid-phosphatidylserine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sarcopenia
×
pembrolizumab
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled